Finance

Beta
Lists
4883:TYO
Modalis Therapeutics Corp
Â¥43.00
0.00%
(0.00) 1D
Jun 1, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4883...
Mkt. cap
4.14B
Avg. vol.
5.92M
Volume
0.00
52-wk high
Â¥119
52-wk low
Â¥42
EPS
-Â¥23
No. of employees
17
Mkt. cap
4.14B
Avg. vol.
5.92M
Volume
0.00
52-wk high
Â¥119
52-wk low
Â¥42
EPS
-Â¥23
No. of employees
17
News stories
From sources across the web
About Modalis Therapeutics Corp
CEOHaru Morita
Employees17
FoundedJan 14, 2016
Headquarters-
SectorBiotechnology
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
334.39M
726.27M
346.41M
293.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
63.73M
56.81M
24.56M
49.00M
Operating expense
398.12M
783.08M
395.97M
342.00M
Total operating expenses
398.12M
783.08M
395.97M
342.00M
Operating income
-398.12M
-783.08M
-395.97M
-342.00M
Other non operating income
46.10M
-2.52M
11.62M
5.00M
EBT including unusual items
-368.22M
-780.69M
-350.53M
-323.00M
EBT excluding unusual items
-368.22M
-779.04M
-350.77M
-323.00M
Income tax expense
-435.00K
625.00K
-300.00K
-
Effective tax rate
0.12%
-0.08%
0.09%
-
Other operating expenses
-
-
25.00M
-
Net income
-367.79M
-781.32M
-350.23M
-323.00M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
2.53M
439.00K
2.00M
Interest expense
-480.00K
-7.92M
-839.00K
-2.00M
Net interest expenses
-480.00K
-5.39M
-400.00K
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-397.82M
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more